Skip to content

Probiotics in Respiratory Tract Infections in Children

Role of Probiotics in Prevention of Respiratory Tract Infections in Preschool and Primary School Children

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01510938
Enrollment
242
Registered
2012-01-18
Start date
2012-01-31
Completion date
2012-12-31
Last updated
2013-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infections, Respiratory Tract

Keywords

Children, Respiratory Tract Infections, Prevention

Brief summary

The purpose of this study is to assess the potential of probiotics in prevention of respiratory tract infections and their complications in children

Interventions

DIETARY_SUPPLEMENTL. acidophilus DDS-1, B. lactis UABLA-12

1 g of probiotic will be reconstituted in 25-50 ml tepid water, juice or age specific baby food and immediately fed once a day (5 billion CFU/daily) for 2-weeks trial period or to the end of acute respiratory infection depending on whatever is longer.

DIETARY_SUPPLEMENTPlacebo

1 g in 25-50 ml of tepid water or juice fed once a day for 2-weeks trial period or to the end of acute respiratory infection depending on whatever is longer.

Sponsors

Lviv National Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
3 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 3-12 yrs * At least one episode of respiratory tract infection in the previous epidemiological season * Direct telephone access available * Informed consent signed

Exclusion criteria

* Vaccination against the influenza * Chronic adeno-tonsillar pathology * Recurrent otitis * Sinusitis * Respiratory allergy * Acute or chronic intestinal disease with diarrhea and/or malabsorption syndrome * Lactose intolerance * Functional or organic constipation * Down syndrome * Congenital or acquired heart disease * Cerebral palsy * Any chronic hepatic, renal, metabolic, or immune system disease

Design outcomes

Primary

MeasureTime frameDescription
Incidence of respiratory tract infection episodes in a child1 monthAn episode will be defined as display of fever, cough, rhinitis, and sore throat or combination thereof for longer than 48 hours

Secondary

MeasureTime frameDescription
Severity of respiratory tract infection21 daysa product of daily CARIFS times the duration of the disease
Complications of respiratory tract infections21 daysPercent of otitis, sinusitis, bronchitis, pneumonia cases
Antibiotic prescriptions21 daysPercent
Hospitalization rate21 daysNumber of hospitalizations
Number of unscheduled doctor visits21 days
Duration of respiratory tract infection21 daysTime to CARIFS (Canadian Acute Respiratory Illness and Flu Scale) value 0
Number of workdays missed by parents21 days
Time to resolution of individual CARIFS item21Days to the correspondent CARIFS item 0
25% and 50% decrease in the CARIFS score21day25% and 50% decrease in the CARIFS score
Percent and duration of the use of over-the-counter medications21dayPercent and duration of the use of over-the-counter medications
Number of days daycare/school missed21 days

Countries

Ukraine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026